RVL Pharmaceuticals (FRA:O1P) Other Operating Expense : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is RVL Pharmaceuticals Other Operating Expense?

RVL Pharmaceuticals's Other Operating Expense for the three months ended in Jun. 2023 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil.

RVL Pharmaceuticals's quarterly Other Operating Expense declined from Dec. 2022 (€0.00 Mil) to Mar. 2023 (€0.00 Mil) and declined from Mar. 2023 (€0.00 Mil) to Jun. 2023 (€-0.00 Mil).

RVL Pharmaceuticals's annual Other Operating Expense declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-0.00 Mil) but then increased from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€0.00 Mil).

RVL Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for RVL Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RVL Pharmaceuticals Other Operating Expense Chart

RVL Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

RVL Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

RVL Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

RVL Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of RVL Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

RVL Pharmaceuticals (FRA:O1P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RVL Pharmaceuticals PLC (FRA:O1P) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

RVLPQ:USA

Address

400 Crossing Boulevard, Bridgewater, NJ, USA, 08807

Website

https://www.rvlpharma.com

RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.

RVL Pharmaceuticals (FRA:O1P) Headlines

No Headlines